DUBLIN, Jan. 26, 2022 /PRNewswire/ — The “U.S. E-Prescribing Market – Industry Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.
The report considers the present scenario of the U.S. e-prescribing market and its market dynamics for the period 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply side of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
E-prescribing uses healthcare technologies to improve prescription accuracy, enhance patient safety, and ensure cost savings. Also, e-prescribing allows real-time, secure, and bi-directional electronic connectivity between prescribers and pharmacies. Telehealth in the country is also growing rapidly as healthcare providers are implementing more sophisticated health IT infrastructures.
The rise in third-party vendors offering add-on telehealth services and advancing practice management tools are allowing to integrate more consults into providers’ workflow, and these advancements will boost the e-prescribing services in the market.
SEGMENTATION ANALYSIS
VENDOR ANALYSIS
SNIPPETS
Prominent Vendors
Other Prominent Vendors
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope Of The Study
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Features Of An Ideal Electronic Prescribing System
7.1.2 Standards For Electronic Prescription Systems
7.1.3 Covid-19 Impact On E-Prescribing In US
8 Market Opportunities & Trends
8.1 Investment In Digital Health & Uptake Of Telehealth Services
8.2 AI To Eradicate Prescription Errors & Develop Indication-Based Prescribing Systems
8.3 Fueling EHR Innovation By Outsourcing E-Prescribing
8.4 Advancements In E-Prescribing Solutions
9 Market Growth Enablers
9.1 Monitoring Use Of Controlled Substances
9.2 Government Initiatives & Incentive Programs For Adopting E-Prescribing
9.3 Automating Clinical Support Decisions & Reducing Manual Prescription Errors
10 Market Growth Restraints
10.1 High Cost Of Deployment & Inadequate Security Concerns
10.2 Incompatible Software Systems & Complex Technologies
10.3 Absence Of Standardized Competence Leading To E-Formulary Errors
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 E-prescribing Type
11.2.2 Delivery Mode
11.2.3 Modality
11.2.4 Medication
11.2.5 End-users
11.3 Five Forces Analysis
12 Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Standard E-Prescribing
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 EPCS
13 Delivery Mode
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Web- & Cloud-Based
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 On-Premise & Desktop
14 Modality
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Integrated
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Standalone
15 Medication Type
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Cardiovascular
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Oncology
15.5 Anti-Infectives
15.6 Behavioral & Mental Health
15.7 Pain Medication
15.8 Others
16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Healthcare Facilities
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.4 EHR, Telehealth, & Pharmacy Software Vendors
16.5 Independent & Specialty Pharmacies
16.6 PBM & Payors
17 Competitive Landscape
17.1 Competition Overview
17.2 Market Share Analysis
17.2.1 Surescripts in E-prescribing Market
17.2.2 DrFirst in E-prescribing Market
17.2.3 Practice Fusion in E-prescribing Market
17.2.4 InSync Healthcare Solutions in E-prescribing Market
For more information about this report visit https://www.researchandmarkets.com/r/olozdl
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…
- Leading efficient care management for the elderly with unimpeded smartcare https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png SEOUL, South Korea, Nov.…
- Attruby is the first and only approved product with aspecifying near-complete stabilization…
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…